Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P44
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -0.96% |
| Q3 2025 | -10.42% |
| Q2 2025 | -19.93% |
| Q1 2025 | 18.73% |
| Q4 2024 | -10.00% |
| Q3 2024 | 0.66% |
| Q2 2024 | 14.91% |
| Q1 2024 | -29.05% |
| Q4 2023 | 12.00% |
| Q3 2023 | -29.77% |
| Q2 2023 | 45.68% |
| Q1 2023 | -26.31% |
| Q4 2022 | -4.10% |
| Q3 2022 | 40.41% |
| Q2 2022 | 1.23% |
| Q1 2022 | 3.15% |
| Q4 2021 | -1.26% |
| Q3 2021 | 10.24% |
| Q2 2021 | 2599.78% |
| Q1 2021 | -105.08% |
| Q4 2020 | -5.93% |
| Q3 2020 | -1.08% |
| Q2 2020 | 55.26% |
| Q1 2020 | 139.67% |
| Q4 2019 | 141.44% |
| Q3 2019 | -0.22% |
| Q2 2019 | -39.44% |
| Q1 2019 | 38.67% |
| Q4 2018 | 24.37% |
| Q3 2018 | 49.30% |
| Q2 2018 | 229.08% |
| Q1 2018 | -179.60% |
| Q4 2017 | -15.62% |
| Q3 2017 | 62.24% |
| Q2 2017 | -14.64% |
| Q1 2017 | 134.67% |
| Q4 2016 | -52.04% |
| Q3 2016 | -16.00% |
| Q2 2016 | 83.88% |
| Q1 2016 | 45.40% |